NASDAQ: PPDI       Pharmaceutical Product Development
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):0
Average Price Target: 33.00
Price Target Upside/Downside: +33.00


No recent Headlines for this stock.

Business Background

Pharmaceutical Product Development, Inc. (PPD) is a global contract research organization providing drug discovery, development and lifecycle management services. The Company's clients and partners include pharmaceutical, biotechnology, medical device, academic, non-profit and government organizations. Its development services include preclinical drug discovery services, programs, Phase I through Phase IV clinical development services and post-approval services, as well as bioanalytical, good manufacturing practices (cGMP), global central laboratory and vaccines and biologics laboratory services. It also offers support, such as medical information, patient compliance programs, patient and disease registry programs, product safety and pharmacovigilance, standard response document development, observational studies, Phase IV monitored studies and prescription-to-over-the-counter (Rx to OTC), programs. It operates in two segments: Clinical Development Services and Laboratory Services.

  Be the first to like this.


5255  3112  425  130 

Top 10 Active Counters
 SPY 296.26-1.25 
 IBIO 2.45+1.585 
 CHK 0.275+0.015 
 EEM 40.52-0.15 
 XLF 26.59-0.74 
 BAC 28.50-0.63 
 GDX 26.22-1.93 
 GE 10.88+0.49 
 QQQ 205.80+1.90 
 VXX 22.81+0.81 
Partners & Brokers